FRARA, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 1.487
NA - Nord America 1.094
EU - Europa 857
SA - Sud America 313
AF - Africa 70
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.845
Nazione #
US - Stati Uniti d'America 1.020
SG - Singapore 593
CN - Cina 409
BR - Brasile 275
IT - Italia 253
HK - Hong Kong 192
SE - Svezia 160
DE - Germania 108
VN - Vietnam 106
RU - Federazione Russa 104
GB - Regno Unito 58
CA - Canada 49
EG - Egitto 35
IR - Iran 33
IN - India 32
FR - Francia 31
ID - Indonesia 22
NL - Olanda 22
AU - Australia 20
JP - Giappone 20
MX - Messico 20
FI - Finlandia 19
ES - Italia 17
AT - Austria 16
PL - Polonia 16
TR - Turchia 16
BD - Bangladesh 14
ZA - Sudafrica 14
AR - Argentina 13
TN - Tunisia 12
CH - Svizzera 10
TW - Taiwan 10
EC - Ecuador 9
IE - Irlanda 9
IQ - Iraq 8
MA - Marocco 6
PE - Perù 6
UA - Ucraina 6
BE - Belgio 5
DK - Danimarca 5
JO - Giordania 5
CO - Colombia 4
LT - Lituania 4
PK - Pakistan 4
AZ - Azerbaigian 3
GR - Grecia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
VE - Venezuela 1
Totale 3.845
Città #
Singapore 275
Dallas 258
Hong Kong 187
Ashburn 135
Shanghai 106
Hefei 75
Milan 71
Beijing 68
New York 48
Los Angeles 39
Princeton 39
Lawrence 38
Moscow 38
Ho Chi Minh City 35
Rome 33
Munich 31
São Paulo 31
Giza 27
Montreal 24
Tehran 23
Nuremberg 20
Hanoi 18
Boardman 15
Denver 13
Seattle 13
Chicago 12
Bologna 11
Gatchina 11
Tokyo 11
Warsaw 11
London 10
Poplar 10
Santa Clara 10
Stockholm 10
Houston 9
Johannesburg 9
Rio de Janeiro 9
Chennai 8
Dublin 8
Frankfurt am Main 8
Vienna 8
Washington 8
Zurich 8
Boston 7
Istanbul 7
Kaohsiung City 7
Manchester 7
Melbourne 7
San Francisco 7
Verona 7
Assago 6
Atlanta 6
Brooklyn 6
Cairo 6
Columbus 6
Guangzhou 6
Helsinki 6
Jakarta 6
Lappeenranta 6
Porto Alegre 6
The Dalles 6
Turku 6
Aachen 5
Ankara 5
Bandung 5
Brussels 5
Cesano Boscone 5
Curitiba 5
Hanover 5
Lima 5
Mumbai 5
Paris 5
Phoenix 5
Shenzhen 5
St Petersburg 5
Toronto 5
Torquay 5
Wilmington 5
Biên Hòa 4
Brasília 4
Cannon Beach 4
Edmonton 4
Ha Long 4
Haiphong 4
Hyderabad 4
Mexico City 4
Niterói 4
Perm 4
Perth 4
Piancogno 4
Pisa 4
Quito 4
Sorocaba 4
Tianjin 4
Yekaterinburg 4
Amman 3
Antibes 3
Baghdad 3
Bauru 3
Beachwood 3
Totale 2.115
Nome #
Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 441
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement 123
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 88
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows 87
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement 82
Acromegalic osteopathy: An update 77
COVID-19 and hypopituitarism 77
Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour? 75
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 71
Novel approach to bone comorbidity in resistant acromegaly 71
COVID-19 and the pituitary 69
Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves' Disease 64
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly 64
Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel 64
CURRENT AND FUTURE MEDICAL TREATMENTS FOR PATIENTS WITH ACROMEGALY. 63
CURRENT AND EMERGING ASPECTS OF DIABETES MELLITUS IN ACROMEGALY. 63
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly (Pituitary, 10.1007/s11102-018-0873-7) 63
Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism 63
Diabetes in Cushing Disease 60
Acromegalic osteopathy 60
An Italian survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 58
Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis 57
Bone safety of dual-release hydrocortisone in patients with hypopituitarism 57
Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination 56
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 55
Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis 52
Vitamin D Levels Are Associated with Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity 52
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 50
Clinical Pharmacology of Oral Octreotide Capsules for the Treatment of Acromegaly 49
Osteopathy in mild adrenal Cushing's syndrome and Cushing disease 48
Pituitary Tumors Centers of Excellence 48
Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors 47
Correction: Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era 46
GH/IGF-I and bone 45
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022 44
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers 44
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly 44
Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis 41
EVIDENCE OF REDUCED MUSCLE MASS NOT ALWAYS ASSOCIATED WITH REDUCED MUSCLE STRENGTH IN POST COVID-19 PATIENTS: is this picture indicative of a recovery from acute sarcopenia 41
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE) 40
High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma 40
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 40
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increase 40
Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients 40
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era 40
Modern approach to resistant acromegaly 39
New tools for bone health assessment in secreting pituitary adenomas 39
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications 39
Vitamin D and Glucocorticoid-Induced Osteoporosis 38
High prevalence of radiological vertebral fractures inpatients With TSH-secreting pituitary adenoma 38
Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response 38
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs 37
New onset of Graves' disease after controlled ovarian stimulation: A case report and brief literature review 37
Skeletal fragility: an emerging complication of Ehlers–Danlos syndrome 37
Treatment of hypoparathyroidism 37
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience 36
Primary hyperparathyroidism in prostate cancer: guilty or not guilty? 36
Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization 35
Somatostatin analogs in the treatment of neuroendocrine tumors: Current and emerging aspects 35
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 34
Pituitary Diseases and Bone 34
Malignancy risk in indeterminate thyroid nodules with Hürthle cells: role of autoimmune thyroiditis 34
THE MODERN CRITERIA FOR MEDICAL MANAGEMENT OF ACROMEGALY 33
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects 32
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine 31
Novel approaches to bone comorbidity in Cushing's disease: an update 31
Pituitary tumor centers of excellence for Cushing's disease 31
Pathophysiology and evaluation of bone health in adrenal diseases 30
TSH-secreting pituitary adenomas and bone 30
The osteo-metabolic phenotype of COVID-19: an update 29
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 29
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas 28
New medical therapies of acromegaly 26
Response to the Letter to the Editor from Min et al.: Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors 24
null 1
Totale 3.977
Categoria #
all - tutte 25.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 2 1 0 0 0 0 0
2021/202222 0 0 0 1 2 0 1 11 3 0 3 1
2022/2023319 81 72 26 11 4 40 18 18 11 2 4 32
2023/2024616 33 37 73 95 61 116 37 79 2 4 28 51
2024/20251.239 138 59 34 50 28 85 214 108 208 84 99 132
2025/20261.743 286 320 321 508 271 37 0 0 0 0 0 0
Totale 3.977